Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

Combivent discontinuation announced

The manufacturer of Combivent® (ipratropium 20micrograms / salbutamol 100micrograms) has announced that the metered dose aerosol inhaler will be discontinued in 2008.

The decision to discontinue this product is based upon European CFC environmental legislation that restricts the use of CFC propellants. There are no concerns about the safety profile, effectiveness or quality of the product.

This product is indicated in the British National Formulary as being less suitable for prescribing.

Action: Clinicians should take this opportunity to review existing treatments. Prescription of ipratropium and salbutamol in separate inhalers is one solution to this discontinuation.

Share 'Combivent discontinuation announced' on Email Share 'Combivent discontinuation announced' on Delicious Share 'Combivent discontinuation announced' on Digg Share 'Combivent discontinuation announced' on Facebook Share 'Combivent discontinuation announced' on Google+ Share 'Combivent discontinuation announced' on reddit Share 'Combivent discontinuation announced' on StumbleUpon Share 'Combivent discontinuation announced' on Twitter

atomic-wealth

No Comments to “Combivent discontinuation announced”

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.
Akismet has protected Prescribing Advice for GPs from 789,521 spam comments.

atomic-wealth
fond-illness
summer